Dumala, Lilia E.

HRN: 28-80-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/06/2026
04/13/2026
IV
300mg
Q6
CELLULITIS
Remove - Pending Acceptance
04/06/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/06/2026
04/12/2026
IV
4.5
Q8h
Cellulitis; DM Foot
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: